Filing Flows › Precigen (PGEN) › Q1 2026
Precigen (PGEN) Q1 2026 earnings results (first quarter 2026)
10-Q filed May 13, 2026
Precigen (PGEN) reported revenue of $23.3M for the first quarter 2026 (Q1 2026), up 17-fold from a year earlier. Operating margin was -25.8%, net loss $7.9M (34.1% of revenue).
Precigen, Q1 2026: revenue $23.3M (17× year over year), operating margin -25.8%, net loss $7.9M, operating cash flow −$43.8M. The chart follows the revenue to costs, profit and cash.
| Q1 2026 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $23.3M | — | 17× |
| Operating profit | −$6.0M | — | — |
| Net earnings | −$7.9M | — | — |
| Operating cash flow | −$43.8M | — | — |
What changed
Revenue was $23.3M in Q1 2026, up 1634% year over year. Papzimeos was the largest line at 93% of revenue. Service revenues added $286K year over year (up 25%), 1% of the total change.
Operating costs exceeded revenue by $6.0M, an operating margin of -25.8%. Total costs grew 22% against revenue growth of 1634%. The fastest-growing cost line was Other operating costs (+133%). The quarter ended with a net loss of $7.9M.
Operating cash flow was −$43.8M. Non-cash charges added back $1.1M of depreciation and amortization and $3.0M of share-based compensation. Working capital and other items used $40.0M. Capital expenditures of $258K exceeded it, leaving free cash flow of −$44.1M.
Questions
What was Precigen's revenue in the first quarter 2026?
Precigen (PGEN) reported revenue of $23.3M for the first quarter 2026 (Q1 2026), up 17-fold from a year earlier.
Was Precigen profitable in the first quarter 2026?
Operating loss was $6.0M (-25.8% of revenue) and net loss $7.9M.
Source: Precigen 10-Q on SEC EDGAR.